Think Research empowers clinicians and healthcare organizations to deliver exceptional care by making evidence-based standardisation available at the point of care. Our solutions support improved decision-making across the care continuum and help you track, meet, and exceed quality improvement and strategic goals.
Our knowledge-based products are tailored to the healthcare and legal environment in the UK and Europe. We’re here to support your coronavirus pandemic response by ensuring your care decisions align with emerging COVID-19 best practice. With VirtualCare, our telemedicine platform, we can also support your efforts to reduce transmission risk.
Reduce variation and align care with clinical best practice
Maintain delivery of care to changing payer standards
Unlock insights with data capture and reporting
Provide cost-effective care that meets your clinical and administrative priorities with our digital healthcare solutions. Learn how our products modernise the delivery and management of healthcare through clinical standardisation, workflow efficiencies, and impactful cost-effective care.
Care Pathways is a decision-support tool that uses research-based clinical knowledge to drive standardisation and exceptional care outcomes. Featuring an industry-leading library of reference pathways, Care Pathways reduces costs and unwanted variation in practice while supporting quality improvement across your department, hospital, trust, and health system.
Reach patients remotely while providing comprehensive, high-quality care. VirtualCare is an award-winning and GDPR-compliant telemedicine platform enabling you to provide care through a web browser or easy-to-use smartphone application. Instead of requiring a clinic visit, deliver your care securely in less time. VirtualCare can assist you in safely treating patients with COVID-19 associated symptoms from their residence or care home.
Progress Notes is a clinical documentation tool providing clinicians an intuitive and structured way to record and access patient information. With integrated clinical knowledge and clinical support features, Progress Notes enhances the day-to-day documentation process while supporting the transition from handwritten paper note-taking.
Discover how Progress Notes helped Wexford General Hospital successfully shift from paper to digital.
eForms is a digital tool that records clinical information in a structured format while delivering new workflow efficiencies. In just a few clicks, clinicians can access the forms they need while the digital format generates time-saving efficiencies and new analytics insights.
Learn how Ireland’s Wexford General Hospital used Progress Notes to improve workflow efficiency, deliver best-practice care, and triple their ROI.
Think Research is a clinical content and technology company based in Toronto, Canada. We’re on a mission to structure the world’s healthcare knowledge and deliver it via connected technology solutions that make doing the right thing for your patients easy.
We’re proud to advance digital healthcare through our clinical standardisation solutions, which remove barriers to outstanding care.
Since our founding in 2006 by critical care clinician Dr. Chris O’Connor, we’ve grown to support over 2,200 client partners in delivering exceptional care on three continents.
With European offices in Ireland and the UK, our clinical staff ensure our solutions and clinical content align to local protocols, national health guidelines, and the problems that matter most to you.
Privacy is essential to our business and products. All Think Research products and cloud-based technology are GDPR compliant.
Tony’s clinical background was in radiography before entering informatics as Programme Director. Prior to serving as Programme Director, he led the first communitywide PACS and then moved on to the Pan London PACS programme, Kent and Medway as Programme Director and SHA deputy CIO.
Tony has been involved in large-scale clinical IM&T projects including EPR/EHR, PACS, RIS, Pathology, covering acute, community, mental health and primary care on a national and international basis. He established, grew and sold Bluestar Group to System C before establishing Cloud21 and CTOi Group. Tony spent over two years as Global Strategic Partnerships lead for Google Deepmind to establish their health business. He is currently completing his doctorate at Warwick Business School, with a focus on developing AI in Healthcare.
Sam was most recently the Director for Digital Development for NHS England. He has a background in primary healthcare, public health, research and supporting the digital transformation of the NHS in England. He has also overseen the development of NHS 111 Online in England.
Sam holds fellowships to the faculties of the Royal College of Surgeons of England, Faculty of Public Health and the Faculty of Clinical Informatics.
Dr Yvonne Smyth is currently a joint Cardiology & Acute Medicine consultant in University Hospital Galway and works privately in Bon Secours Hospital Galway. Her areas of interest include cardiovascular imaging and heart failure.
She undertook a subspecialty fellowship in Cardiovascular Imaging in the Cleveland Clinic USA and achieved level III board certification from the American Society of Echocardiography in 2008 and 2018. Dr Smyth graduated from NUIG in 1997. She has a MA in Healthcare Management, Diploma in Clinical Education and is a fellow of the Royal College of Physicians in Ireland.
David is a Senior Clinical Lecturer at the University of Exeter Medical School, an honorary consultant in medicine for the older adult, a member of the UK Board of science and the co-chair of the British Medical Association’s medical academic staff committee. Clinically, he runs a community diabetes service for the older adult, works with the Chronic Fatigue Service team, and works as an in-patient stroke consultant.
In a pre-COVID world, his main research focus was the health of older adults; ensuring the right patient gets the right treatment. This includes population based research on pragmatic interventions, right down to mechanistic work exploring of benefits of medications which may offer the ability to repurpose drugs. He has performed the only study to date demonstrating the feasibility of individualizing targets for older adults across Europe. This has informed the new UK guidance document for the management of older adults with diabetes and frailty, of which he was lead author.
Since March 2020, he has been heavily involved in COVID-19. He is the Clinical Lead for COVID at the Royal Devon & Exeter Hospital, and has both run the COVID wards and been part of the team that established the SW long Covid Service. He is the Chief investigator of a study looking at the genetics of long COVID, the BMA lead for long COVID, and has participated in the NHS Long-COVID taskforce and the APPG on the same subject.
Steve joined Lloyds Chemists as a Pharmacy Manager managing several different sized community pharmacies, and spent a decade as Training and Development Director for the Group and set up and established the Internal Communications function. Steve was the Superintendent Pharmacist for 11 years and for the last two years had the additional responsibility as Clinical Standards Director, responsible for clinical leadership across all patient facing environments in the diverse McKesson UK organisation. Steve is a visiting Professor at the University of Huddersfield and the University of East Anglia, Accreditation and Recognition Team Leader for the General Pharmaceutical Council, Non Executive Clinical Director McKesson UK and an Executive Coach and Mentor.
Chris established the company’s EU operations in 2016 and is primarily responsible for corporate affairs and business development. Over his career, Chris has worked as a consultant for over 40 companies and organizations across a wide range of industry sectors, ICT, Healthcare, Information Technology, and Public Affairs. Chris previously served as an adviser to the Canadian Prime Minister, Minister of Industry and Minister of Health.
He holds a BA in History from Carleton University, Ottawa; an LL. B from Trinity College, Dublin; and a Diploma in Legal French from the Chamber of Commerce and Industry of Paris; and a Diploma in Company Direction from the Institute of Directors, London.
Chris also serves as Chairperson of the Ireland-Canada Business Association, a Consultant to Philip Lee Solicitors, and sits on the Board of Trustees of the Ireland-Canada University Foundation.
David Schmeler is a recognized leader in Canadian business, with a career spanning more than 20 years across healthcare, technology and transportation industries.
David has dedicated the past 13 years to supporting the Canadian healthcare market, launching communication and technology services for pharmaceutical firms and the broader healthcare professional community.
As head of global sales at subsidiary MDBriefCase, David manages joint ventures and drives the expansion of MDBriefCase’s online learning platform into new global markets.
Sinead is Think Research’s clinical advisor and programme manager with oversight of our EU and UK projects. With over 15 years experience in Irish healthcare, she is responsible for operations, product delivery and project success.
Sinead trained as a radiotherapist, graduating with a BSc. from Trinity College School of Medicine and has completed a master’s degree in Clinical Research at the London School of Hygiene and Tropical Medicine. Sinead has taught at a master’s level at the University of Dublin, Trinity College, where she is the Head of Clinical Sponsorship Oversight for their clinical research portfolio. Prior to joining Think Research, Sinead worked for IQVIA, a multinational bio-pharmaceutical contract research organisation.
Sinead has recently received a GDPR Certificate from the University of Groningen and has a certificate in advanced SNOMED-CT Clinical Coding implementation methodologies with the IHTSDO.
As Think Research’s leader for International Growth, Corporate Development, and Partnerships, Joel is responsible for developing our strategy for international markets and building the company’s global reach.
Joel joined Think Research in Toronto in 2019 after over 20 years in healthcare consulting and healthcare venture capital – more than half of which was spent overseas – in the Middle East, Africa, and the UK.
Joel has worked on major health system reform programs and is well-versed with the challenges health systems face globally: their struggles with access, quality and cost, and the opportunities for new technologies and reimbursement models to reach health system goals.
Joel is leading our international efforts and is establishing a series of direct and indirect channels including putting in place partnerships with health systems, health technology providers, and payers in the UK, Australia, and in the Middle East and Africa.
Joel is on an extended secondment from iGan Partners, a major shareholder in Think Research. He remains a Partner in the healthcare fund. Formerly, he was a Partner and Practice Leader with PwC in the Middle East. Prior to that, he was a career consultant at strategy consultancy Monitor Group. He is a Director of the Royal College of Physicians and Surgeons of Canada, and a Fellow of the Creative Destruction Lab in Toronto.
Dr Harpreet Sood is a non-executive director of Health Education England and a former Associate Chief Clinical Information Officer with NHS England. Previously, he was Senior Fellow to the CEO of NHS England. Harpreet trained as a clinical doctor at King’s College London and Imperial College Business School and practiced as a doctor in East London.
Following this he undertook a Masters Degree in Public Health (MPH) at Harvard University where he focused on international health policy and co-founded a digital health start-up.
Harpreet was also a Deland Fellow in health policy and management at Brigham and Women’s Hospital.
